Nazione: Svizzera
Lingua: tedesco
Fonte: Swissmedic (Swiss Agency for Therapeutic Products)
levocabastinum
Janssen-Cilag AG
S01GX02
levocabastinum
Augentropfensuspension
levocabastinum 0.5 mg ut levocabastini hydrochloridum, propylenglycolum, dinatrii phosphas et natrii dihydrogenophosphas monohydricus corresp. phosphas 9.5 mg, benzalkonii chloridum 0.15 mg, hypromellosum, polysorbatum 80, dinatrii edetas, aqua ad iniectabile q.s. ad solutionem pro 1 ml.
D
Synthetika
Allergische Konjunktivitis
2009-06-25